Dairy Goat Co-operative expands into China and US

That matters because China and the US are among the most expensive markets for infant formula makers to enter and defend. Companies need clinical evidence, regulatory clearances and established distribution, all of which can consume cash long before sales scale.

DGC, which has 55 farmer shareholders in Waikato and Taranaki and employs 240 people at its Hamilton manufacturing base, said the new money will help it move faster without changing the ownership model that has underpinned the business since its early commercialization in the late 1980s and early 1990s. The co-op pioneered goat milk infant formula and has long sold into Asia, with trade links to Taiwan dating back to 1989 before later expansion into Thailand and South Korea.

Hulbert said consumers choose goat-milk formula for perceived digestive benefits, and the company says its product can help prevent eczema in babies. It added that it now has “robust clinical research,” including a study tracking 2,300 babies from birth to age five in a project run by LMU Munich.

For investors, the deal is a bet that premium, science-backed infant nutrition can keep winning shelf space even as competition and compliance costs rise. It also points to a broader push among specialty dairy exporters to move beyond established Asian markets and into the larger but more demanding US-China corridor.

The next test is execution: regulatory approvals, clinical validation and distribution build-out in both markets will determine whether the co-op can turn its niche brand into a larger export platform.